CEOcast, Inc. for Advanced Cell Technology Advanced Cell Technology, Inc. (“ACT”) (OTC: ACTC) announced today that Dr. Robert Lanza, M.D., the company’s Chief Scientific Officer, and Dr. Tao Cheng are Conference Co-Chairs of the International Forum on Stem Cells, held October 16-18th in Tianjin, China. Dr. Lanza will Chair the opening session of the Conference, which includes Keynote Presentations by Professor Sir Ian Wilmut, Chair of Reproductive Biology and Director of the Scottish Centre for Regenerative Medicine, University of Edinburgh, UK, and Dr. Darwin Prockop, Stearman Chair in Genomic Medicine at Texas A&M College of Medicine and Institute for Regenerative Medicine at Scott & White. CEOcast, Inc. for Advanced Cell Technology
Daniel Schustack, 212-732-4300
Advanced Cell Technology, Inc. (“ACT”) (OTC: ACTC) announced today that Dr. Robert Lanza, M.D., the company’s Chief Scientific Officer, and Dr. Tao Cheng are Conference Co-Chairs of the International Forum on Stem Cells, held October 16-18th in Tianjin, China. The conference is organized by the Chinese Academy of Medical Sciences (CAMS) and the National Science Foundation of China. According to the organizers, “The timing, location and booming economy in China offer new exciting opportunities to launch some joint international efforts on stem cell research and applications.”
Dr. Lanza will Chair the opening session of the Conference, which includes Keynote Presentations by Professor Sir Ian Wilmut, Chair of Reproductive Biology and Director of the Scottish Centre for Regenerative Medicine, University of Edinburgh, UK, and Dr. Darwin Prockop, Stearman Chair in Genomic Medicine at Texas A&M College of Medicine and Institute for Regenerative Medicine at Scott & White.
The conference will include speakers and presenters from stem cell companies and leading academic researchers. Dr. Shi-Jiang Lu, Ph.D., ACT’s Director of Stem Cell Differentiation, will discuss the biological properties of hemangioblasts derived from human embryonic stem cells. Other agenda topics include:
— Embryonic stem cell derivation and maintenance
— Embryonic or germ line stem cell differentiation
— Reprogramming and “iPS”cells
— Somatic stem cells
— Pathogenic stem cells
— Stem cell transplant and tissue engineering
— Stem cell manipulations and drug discovery
— Stem cell applications and business models
— Open discussion on potential international collaborations and advantages of doing stem cell research/business in China
For more information, visit:
http://www.selectbiosciences.com/conferences/IFSC2008/
Forward-Looking Statements
About Advanced Cell Technology, Inc.
Advanced Cell Technology, Inc. is a biotechnology company applying cellular technology in the emerging field of regenerative medicine. For more information, visit http://www.advancedcell.com.
Forward-Looking Statements
Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words “will,” “believes,” “plans,” “anticipates,” “expects,” “estimates,” and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward- looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company’s periodic reports, including the report on Form 10-QSB for the quarter ended September 30, 2007. Forward-looking statements are based on the beliefs, opinions, and expectations of the company’s management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change.
Forward-looking statements are based on the beliefs, opinions, and expectations of the company’s management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change.
(c) 2008 BUSINESS WIRE. Provided by ProQuest LLC. All rights Reserved.
A service of YellowBrix, Inc.
